ZENCELL Trademark

Trademark Overview


On Wednesday, April 29, 2026, a trademark application was filed for ZENCELL with the United States Patent and Trademark Office. The USPTO has given the ZENCELL trademark a serial number of 79450387. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, May 21, 2026. This trademark is owned by Skin Solutions Architect Pty Ltd. The ZENCELL trademark is filed in the Pharmaceutical Products category with the following description:

Acne treatment products in gel form; products in gel form for the treatment of acne; pharmaceutical preparations for the treatment of eczema; gels for dermatological use.
zencell

General Information


Serial Number79450387
Word MarkZENCELL
Filing DateWednesday, April 29, 2026
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateThursday, May 21, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing0 - NOT AVAILABLE
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesAcne treatment products in gel form; products in gel form for the treatment of acne; pharmaceutical preparations for the treatment of eczema; gels for dermatological use.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, May 21, 2026
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSkin Solutions Architect Pty Ltd
Party Type10 - Original Applicant
Legal Entity Type98 - Unknown
AddressAU

Trademark Events


Event DateEvent Description
Thursday, May 21, 2026SN ASSIGNED FOR SECT 66A APPL FROM IB